Skip to main content
Premium Trial:

Request an Annual Quote

Cartagenia Raises $2.9M in Private Financing

NEW YORK (GenomeWeb News) – Cartagenia, a Leuven, Belgium-based firm developing software and database systems for genetic analyses, today said that it has received a capital injection of €2.2 million ($2.9 million).

The company said that it would use the funds to further develop its market presence, open an office in the US, and invest in a new product line.

Cartagenia's Bench platform is a web-based data solution intended to support interpretation of genomic variation in clinical diagnostics. According to the firm's website, the platform helps clinicians quickly and accurately select relevant genetic information that can be used in diagnosis and counseling.

Half of the capital injection came from existing investors PMV/VINNOF, Gemma Frisius Fund, and founders of the firm. The other half was provided by Belgian investment firm Quest for Growth.

"This capital increase will help us strengthen our market presence and accelerate the development of certain products," Cartagenia CEO Herman Verrelst said in a statement. "We are particularly excited about the opportunity to expand our business to supporting clinical genetic diagnosis based on [next-generation sequencing] data. We also want to respond to the growing demand to support prenatal screening and cancer diagnosis."

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.